1 week Ago By ABMN Staff
Arrowstreet Capital Limited Partnership increased its stake in Maximus, Inc. ( NYSE:MMS – Free Report ) by 108.5% in the 4th quarter, according to its most recent disclosure with the SEC.
The institutional investor owned 84,309 shares of the health services provider’s stock after acquiring an additional 43,864 shares during the period. Arrowstreet Capital Limited Partnership owned about 0.15% of Maximus worth $6,294,000 as of its most recent SEC filing.
A number of other institutional investors have also added to or reduced their stakes in MMS. UMB Bank n.a.
raised its stake in shares of Maximus by 79.8% during the fourth quarter. UMB Bank n.
a. now owns 356 shares of the health services provider’s stock worth $27,000 after acquiring an additional 158 shares in the last quarter. Eastern Bank purchased a new position in Maximus in the 4th quarter worth $29,000.
V Square Quantitative Management LLC lifted its stake in Maximus by 65.9% in the fourth quarter. V Square Quantitative Management LLC now owns 453 shares of the health services provider’s stock worth $34,000 after purchasing an additional 180 shares during the last quarter.
R Squared Ltd purchased a new stake in Maximus during the fourth quarter valued at about $54,000. Finally, IFP Advisors Inc grew its stake in shares of Maximus by 62.4% during the fourth quarter.
IFP Advisors Inc now owns 786 shares of the health services provider’s stock valued at $59,000 after buying an additional 302 shares during the last quarter. Institutional investors own 97.21% of the company’s stock.
Wall Street Analysts Forecast Growth Several equities research analysts recently weighed in on the company. StockNews.com cut Maximus from a “buy” rating to a “hold” rating in a report on Friday, February 14th.
Raymond James raised Maximus from a “market perform” rating to an “outperform” rating and set a $90.00 price objective for the company in a research note on Thursday, January 2nd. Maximus Stock Performance Shares of NYSE:MMS opened at $67.
36 on Tuesday. The company has a current ratio of 1.72, a quick ratio of 1.
72 and a debt-to-equity ratio of 0.82. The company has a 50-day moving average price of $68.
94 and a 200-day moving average price of $76.96. The company has a market cap of $3.
81 billion, a price-to-earnings ratio of 14.49 and a beta of 0.68.
Maximus, Inc. has a 12 month low of $63.77 and a 12 month high of $93.
97. Maximus ( NYSE:MMS – Get Free Report ) last released its quarterly earnings data on Thursday, February 6th. The health services provider reported $1.
61 earnings per share for the quarter, topping the consensus estimate of $1.39 by $0.22.
Maximus had a return on equity of 21.95% and a net margin of 5.28%.
As a group, equities analysts anticipate that Maximus, Inc. will post 6.15 EPS for the current year.
Maximus Dividend Announcement The business also recently disclosed a quarterly dividend, which will be paid on Saturday, May 31st. Shareholders of record on Thursday, May 15th will be issued a $0.30 dividend.
This represents a $1.20 annualized dividend and a yield of 1.78%.
Maximus’s dividend payout ratio (DPR) is presently 25.81%. Insider Transactions at Maximus In other news, Director Jan Madsen sold 2,439 shares of the firm’s stock in a transaction that occurred on Tuesday, March 18th.
The stock was sold at an average price of $67.71, for a total value of $165,144.69.
Following the completion of the transaction, the director now owns 18,097 shares in the company, valued at $1,225,347.87. This trade represents a 11.
88 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink . Also, insider Ilene R.
Baylinson sold 14,500 shares of the company’s stock in a transaction on Wednesday, February 19th. The stock was sold at an average price of $68.14, for a total value of $988,030.
00. Following the completion of the sale, the insider now directly owns 2,512 shares in the company, valued at approximately $171,167.68.
The trade was a 85.23 % decrease in their ownership of the stock. The disclosure for this sale can be found here .
Corporate insiders own 1.60% of the company’s stock. Maximus Company Profile ( Free Report ) Maximus, Inc operates as a provider of government services in the United States and internationally.
It operates through three segments: U.S. Federal Services, U.
S. Services, and Outside the U.S.
The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.
Featured Stories Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter ..
